Posaconazole
Brand name: Posaconazole
Rank #439 of 500 drugs by total cost
$18.0M
Total Cost
7,163
Total Claims
$18.0M
Total Cost
339
Prescribers
$2,517
Cost per Claim
438
Beneficiaries
7,327
30-Day Fills
$53K
Avg Cost/Provider
21
Avg Claims/Provider
About Posaconazole
Posaconazole (sold as Posaconazole) was prescribed 7,163 times by 339 Medicare Part D providers in 2023, costing the program $18.0M. At $2,517 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 436 | Methylprednisolone (Methylprednisolone) | $18.9M | 1,934,494 |
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology